Clinical trial

To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus…

NCT00238667 · St George's, University of London, Other · Completed

Key facts

NCT number NCT00238667
Title To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection
Official title Cervical Artery Dissection in Stroke Study
Acronym CADISS
Lead sponsor St George's, University of London, Other
Collaborators The Stroke Association, United Kingdom
Status Completed
Phase Phase 3
Study type Interventional
Conditions Cervical Artery Dissection, Carotid Artery Dissection, Vertebral Artery Dissection, Stroke
Intervention type Drug
Interventions Antiplatelet (Aspirin, Dipyridamole, clopidogrel), Anticoagulant (Unfractionated Heparin, LMW Heparin, Warfarin)
Enrollment 250
Start date Nov 1, 2005
Completion May 1, 2014
First posted Oct 13, 2005
Last update posted May 20, 2015
Countries United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies